Advertising

NASDAQ:VKTX

2.28
0.01 (0.44%) 1d
0
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
PAST TOP PICK
(A Top Pick Mar 02/21, Down 29.2%)Stockchase Research Editor: Michael O'Reilly Our PAST TOP PICK with VKTX has triggered its stop loss at $6.50. To remain disciplined, we recommend covering the position at this time. We will look for better opportunities.
Pharma & Healthcare

Unlock Panic-Proof Portfolio and Top Stock Picks

Become a member Or, Sign In
TOP PICK
Stockchase Research Editor: Michael O'Reilly VKTX is a pharma company that develops treatments for things such as fatty liver disease, type 2 diabetes and kidney disease to name a few. There are some promising products in development. The company has over 54% of its shares owned by institutions -- signaling key staying power. Analysts expect EPS growth over the next 5 years of 40% annually. We would buy this with a stop-loss at $6.50, looking to target $14.00 - upside potential over 47%. Yield 0% (Analysts’ price target is $14.00)
Pharma & Healthcare
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Viking Therapeutics, Inc.(VKTX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Viking Therapeutics, Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Viking Therapeutics, Inc.(VKTX-Q) Frequently Asked Questions

What is Viking Therapeutics, Inc. stock symbol?

Viking Therapeutics, Inc. is a American stock, trading under the symbol VKTX-Q on the NASDAQ (VKTX). It is usually referred to as NASDAQ:VKTX or VKTX-Q

Is Viking Therapeutics, Inc. a buy or a sell?

In the last year, there was no coverage of Viking Therapeutics, Inc. published on Stockchase.

Is Viking Therapeutics, Inc. a good investment or a top pick?

Viking Therapeutics, Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for Viking Therapeutics, Inc..

Why is Viking Therapeutics, Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Viking Therapeutics, Inc. worth watching?

0 stock analysts on Stockchase covered Viking Therapeutics, Inc. In the last year. It is a trending stock that is worth watching.

What is Viking Therapeutics, Inc. stock price?

On 2022-05-20, Viking Therapeutics, Inc. (VKTX-Q) stock closed at a price of $2.28.